The Central Drugs Standard Control Organisation (CDSCO) has initiated a significant reshuffle, transferring around 95 officials, including assistant drug controllers and drug inspectors, across India. The transfer orders, dated April 17, emphasize public interest and are aimed at addressing compliance gaps within the pharmaceutical sector, which is a crucial contributor to India's economy, valued at over $50 billion. Industry experts suggest that the reshuffle is intended to mitigate undue influence from long-serving officials, which can complicate enforcement and regulatory integrity. The reshuffle adheres to a structured transfer policy that mandates officials to rotate after completing three years at a location. This policy also imposes a ten-year cap on postings in major metropolitan areas, targeting regulatory capture in key pharmaceutical hubs such as Mumbai, Hyderabad, and Ahmedabad. Some industry insiders view this as a routine exercise, while others believe it reflects a broader overhaul outlined in the 2026 union budget.